John Hamer is managing director for Monsanto Growth Ventures, the investment arm of Monsanto which seeks to foster the growth of an innovation supply chain that includes researchers, entrepreneurs, venture capitalists and emerging high-technology companies.
John’s career spans more than three decades of research, senior management, and investment experience in the life sciences. Most recently, he spent nine years with Burrill & Company. Prior to joining Burrill & Company, Hamer was the CSO and later CEO of Paradigm Genetics/ICORIA, a leading genomics and ag-biotechnology company that completed its IPO in 2000 and was later acquired by Monsanto.
John received his PhD in microbiology from UC Davis, and was a visiting scientist in DuPont’s Central Research & Development Group. He’s the recipient of several national awards, including the David & Lucille Packard Award and the National Science Foundation Presidential Faculty Fellowship.